                         SEQUENCE LISTING

<110>  The Board of Trustees of the Leland Stanford Junior 
       University
 
<120>  Compositions and Methods for Enhancing Immunogenic 
       Cross-Presentation of Tumor Antigens

<130>  STAN-1284WO

<140>  PCT/US2017/045577
<141>  2017-08-04

<150>  62/374,477
<151>  2016-08-12

<160>  12    

<170>  PatentIn version 3.5

<210>  1
<211>  413
<212>  PRT
<213>  Artificial sequence

<220>
<223>  synthetic polypeptide

<400>  1

Met Tyr Arg Met Gln Leu Leu Ser Cys Ile Ala Leu Ser Leu Ala Leu 
1               5                   10                  15      


Val Thr Asn Ser Leu Asn Gly Cys Ala Asn Pro Leu Gly Leu Lys Asn 
            20                  25                  30          


Asn Ser Ile Pro Asp Lys Gln Ile Thr Ala Ser Ser Ser Tyr Lys Thr 
        35                  40                  45              


Trp Gly Leu His Leu Phe Ser Trp Asn Pro Ser Tyr Ala Arg Leu Asp 
    50                  55                  60                  


Lys Gln Gly Asn Phe Asn Ala Trp Val Ala Gly Ser Tyr Gly Asn Asp 
65                  70                  75                  80  


Gln Trp Leu Gln Val Asp Leu Gly Ser Ser Lys Glu Val Thr Gly Ile 
                85                  90                  95      


Ile Thr Gln Gly Ala Arg Asn Phe Gly Ser Val Gln Phe Val Ala Ser 
            100                 105                 110         


Tyr Lys Val Ala Tyr Ser Asn Asp Ser Ala Asn Trp Thr Glu Tyr Gln 
        115                 120                 125             


Asp Pro Arg Thr Gly Ser Ser Lys Ile Phe Pro Gly Asn Trp Asp Asn 
    130                 135                 140                 


His Ser His Lys Lys Asn Leu Phe Glu Thr Pro Ile Leu Ala Arg Tyr 
145                 150                 155                 160 


Val Arg Ile Leu Pro Val Ala Trp His Asn Arg Ile Ala Leu Arg Leu 
                165                 170                 175     


Glu Leu Leu Gly Cys Gly Gly Gly Gly Ser Asp Lys Thr His Thr Cys 
            180                 185                 190         


Pro Pro Cys Pro Ala Pro Glu Leu Leu Gly Gly Pro Ser Val Phe Leu 
        195                 200                 205             


Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile Ser Arg Thr Pro Glu 
    210                 215                 220                 


Val Thr Cys Val Val Val Asp Val Ser His Glu Asp Pro Glu Val Lys 
225                 230                 235                 240 


Phe Asn Trp Tyr Val Asp Gly Val Glu Val His Asn Ala Lys Thr Lys 
                245                 250                 255     


Pro Arg Glu Glu Gln Tyr Asn Ser Thr Tyr Arg Val Val Ser Val Leu 
            260                 265                 270         


Thr Val Leu His Gln Asp Trp Leu Asn Gly Lys Glu Tyr Lys Cys Lys 
        275                 280                 285             


Val Ser Asn Lys Ala Leu Pro Ala Pro Ile Glu Lys Thr Ile Ser Lys 
    290                 295                 300                 


Ala Lys Gly Gln Pro Arg Glu Pro Gln Val Tyr Thr Leu Pro Pro Ser 
305                 310                 315                 320 


Arg Glu Glu Met Thr Lys Asn Gln Val Ser Leu Thr Cys Leu Val Lys 
                325                 330                 335     


Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu Trp Glu Ser Asn Gly Gln 
            340                 345                 350         


Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro Val Leu Asp Ser Asp Gly 
        355                 360                 365             


Ser Phe Phe Leu Tyr Ser Lys Leu Thr Val Asp Lys Ser Arg Trp Gln 
    370                 375                 380                 


Gln Gly Asn Val Phe Ser Cys Ser Val Met His Glu Ala Leu His Asn 
385                 390                 395                 400 


His Tyr Thr Gln Lys Ser Leu Ser Leu Ser Pro Gly Lys 
                405                 410             


<210>  2
<211>  386
<212>  PRT
<213>  Artificial sequence

<220>
<223>  synthetic polypeptide

<400>  2

Met Tyr Arg Met Gln Leu Leu Ser Cys Ile Ala Leu Ser Leu Ala Leu 
1               5                   10                  15      


Val Thr Asn Ser Thr Ser Glu Thr Val Val Thr Glu Val Leu Gly His 
            20                  25                  30          


Arg Val Thr Leu Pro Cys Leu Tyr Ser Ser Trp Ser His Asn Ser Asn 
        35                  40                  45              


Ser Met Cys Trp Gly Lys Asp Gln Cys Pro Tyr Ser Gly Cys Lys Glu 
    50                  55                  60                  


Ala Leu Ile Arg Thr Asp Gly Met Arg Val Thr Ser Arg Lys Ser Ala 
65                  70                  75                  80  


Lys Tyr Arg Leu Gln Gly Thr Ile Pro Arg Gly Asp Val Ser Leu Thr 
                85                  90                  95      


Ile Leu Asn Pro Ser Glu Ser Asp Ser Gly Val Tyr Cys Cys Arg Ile 
            100                 105                 110         


Glu Val Pro Gly Trp Phe Asn Asp Val Lys Ile Asn Val Arg Leu Asn 
        115                 120                 125             


Leu Gln Arg Ala Ser Thr Thr Thr Asp Glu Lys Phe Asn Leu Lys Leu 
    130                 135                 140                 


Val Ile Lys Pro Ala Lys Val Thr Pro Ala Gly Gly Gly Gly Ser Asp 
145                 150                 155                 160 


Lys Thr His Thr Cys Pro Pro Cys Pro Ala Pro Glu Leu Leu Gly Gly 
                165                 170                 175     


Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile 
            180                 185                 190         


Ser Arg Thr Pro Glu Val Thr Cys Val Val Val Asp Val Ser His Glu 
        195                 200                 205             


Asp Pro Glu Val Lys Phe Asn Trp Tyr Val Asp Gly Val Glu Val His 
    210                 215                 220                 


Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr Asn Ser Thr Tyr Arg 
225                 230                 235                 240 


Val Val Ser Val Leu Thr Val Leu His Gln Asp Trp Leu Asn Gly Lys 
                245                 250                 255     


Glu Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu Pro Ala Pro Ile Glu 
            260                 265                 270         


Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln Val Tyr 
        275                 280                 285             


Thr Leu Pro Pro Ser Arg Glu Glu Met Thr Lys Asn Gln Val Ser Leu 
    290                 295                 300                 


Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu Trp 
305                 310                 315                 320 


Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro Val 
                325                 330                 335     


Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser Lys Leu Thr Val Asp 
            340                 345                 350         


Lys Ser Arg Trp Gln Gln Gly Asn Val Phe Ser Cys Ser Val Met His 
        355                 360                 365             


Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser Leu Ser Leu Ser Pro 
    370                 375                 380                 


Gly Lys 
385     


<210>  3
<211>  366
<212>  PRT
<213>  Artificial sequence

<220>
<223>  synthetic polypeptide

<400>  3

Met Tyr Arg Met Gln Leu Leu Ser Cys Ile Ala Leu Ser Leu Ala Leu 
1               5                   10                  15      


Val Thr Asn Ser Ala Gly Ser Val Lys Val Gly Gly Glu Ala Gly Pro 
            20                  25                  30          


Ser Val Thr Leu Pro Cys His Tyr Ser Gly Ala Val Thr Ser Met Cys 
        35                  40                  45              


Trp Asn Arg Gly Ser Cys Ser Leu Phe Thr Cys Gln Asn Gly Ile Val 
    50                  55                  60                  


Trp Thr Asn Gly Thr His Val Thr Tyr Arg Lys Asp Thr Arg Tyr Lys 
65                  70                  75                  80  


Leu Leu Gly Asp Leu Ser Arg Arg Asp Val Ser Leu Thr Ile Glu Asn 
                85                  90                  95      


Thr Ala Val Ser Asp Ser Gly Val Tyr Cys Cys Arg Val Glu His Arg 
            100                 105                 110         


Gly Trp Phe Asn Asp Met Lys Ile Thr Val Ser Leu Glu Ile Val Pro 
        115                 120                 125             


Pro Lys Val Thr Thr Asp Gly Gly Gly Gly Ser Asp Lys Thr His Thr 
    130                 135                 140                 


Cys Pro Pro Cys Pro Ala Pro Glu Leu Leu Gly Gly Pro Ser Val Phe 
145                 150                 155                 160 


Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile Ser Arg Thr Pro 
                165                 170                 175     


Glu Val Thr Cys Val Val Val Asp Val Ser His Glu Asp Pro Glu Val 
            180                 185                 190         


Lys Phe Asn Trp Tyr Val Asp Gly Val Glu Val His Asn Ala Lys Thr 
        195                 200                 205             


Lys Pro Arg Glu Glu Gln Tyr Asn Ser Thr Tyr Arg Val Val Ser Val 
    210                 215                 220                 


Leu Thr Val Leu His Gln Asp Trp Leu Asn Gly Lys Glu Tyr Lys Cys 
225                 230                 235                 240 


Lys Val Ser Asn Lys Ala Leu Pro Ala Pro Ile Glu Lys Thr Ile Ser 
                245                 250                 255     


Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln Val Tyr Thr Leu Pro Pro 
            260                 265                 270         


Ser Arg Glu Glu Met Thr Lys Asn Gln Val Ser Leu Thr Cys Leu Val 
        275                 280                 285             


Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu Trp Glu Ser Asn Gly 
    290                 295                 300                 


Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro Val Leu Asp Ser Asp 
305                 310                 315                 320 


Gly Ser Phe Phe Leu Tyr Ser Lys Leu Thr Val Asp Lys Ser Arg Trp 
                325                 330                 335     


Gln Gln Gly Asn Val Phe Ser Cys Ser Val Met His Glu Ala Leu His 
            340                 345                 350         


Asn His Tyr Thr Gln Lys Ser Leu Ser Leu Ser Pro Gly Lys 
        355                 360                 365     


<210>  4
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  synthetic polypeptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(5)
<223>  Amino acids at positions 1 to 5 may be repeated one, two, three, 
       four, five, six, seven, eight, nine, ten, or greater than ten 
       times

<400>  4

Gly Ser Gly Gly Ser 
1               5   


<210>  5
<211>  6
<212>  PRT
<213>  Artificial sequence

<220>
<223>  synthetic polypeptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(6)
<223>  Amino acids at positions 1 to 6 may be repeated one, two, three, 
       four, five, six, seven, eight, nine, ten, or greater than ten 
       times.

<400>  5

Gly Gly Ser Gly Gly Ser 
1               5       


<210>  6
<211>  4
<212>  PRT
<213>  Artificial sequence

<220>
<223>  synthetic polypeptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(4)
<223>  Amino acids at positions 1 to 4 may be repeated one, two, three, 
       four, five, six, seven, eight, nine, ten, or greater than ten 
       times.

<400>  6

Gly Gly Gly Ser 
1               


<210>  7
<211>  4
<212>  PRT
<213>  Artificial sequence

<220>
<223>  synthetic polypeptide

<400>  7

Gly Gly Ser Gly 
1               


<210>  8
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  synthetic polypeptide

<400>  8

Gly Gly Ser Gly Gly 
1               5   


<210>  9
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  synthetic polypeptide

<400>  9

Gly Ser Gly Ser Gly 
1               5   


<210>  10
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  synthetic polypeptide

<400>  10

Gly Ser Gly Gly Gly 
1               5   


<210>  11
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  synthetic polypeptide

<400>  11

Gly Gly Gly Ser Gly 
1               5   


<210>  12
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  synthetic polypeptide

<400>  12

Gly Ser Ser Ser Gly 
1               5   


